Search Results - "Stroncek, D"

Human natural killer cell manufacturing using a closed system process for patients with metastatic solid tumors or hematologic malignancies by Jin, J, Reger, R, Panch, S, Childs, R, Stroncek, D, Highfill, S.L

“…Background & AimAs potent effectors of the innate immune system natural killer (NK) cells are currently utilized in clinical trials world-wide to treat a…”
Get full text

A phase I study of HERV-E TCR transduced autologous T Cells (HERV-E TCR T Cells) in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) by Nadal, R., Cherkasova, E., Barisic, S., Granadier, D., Aue, G., Wells, B., Hawks, G., Hughes, T., Shalabi, R., Stroncek, D., Highfill, S., Scurti, G., Chen, L., Reger, R., Nishimura, M., Childs, R.

Get full text

Persistence of recipient plasma cells and anti‐donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non‐myeloablative haematopoietic cell transplantation by Griffith, L. M., McCoy, J. P., Bolan, C. D., Stroncek, D. F., Pickett, A. C., Linton, G. F., Lundqvist, A., Srinivasan, R., Leitman, S. F., Childs, R. W.

“…Summary Delayed donor erythropoiesis and pure red‐cell aplasia (PRCA) complicate major‐ABO mismatched non‐myeloablative allogeneic stem‐cell transplantation…”
Get full text

The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort by Heim, K.F., Fleisher, T.A., Stroncek, D.F., Holland, S.M., Gallin, J.I., Malech, H.L., Leitman, S.F.

“…BACKGROUND: The efficacy of granulocyte transfusions in patients with HLA alloimmunization is uncertain. A flow cytometric assay using dihydrorhodamine 123…”
Get full text

immunologic aspects of poxvirus oncolytic therapy by Worschech, Andrea, Haddad, D, Stroncek, D. F, Wang, E, Marincola, Francesco M, Szalay, Aladar A

“…The concept of using replicating oncolytic viruses in cancer therapy dates to the beginning of the twentieth century. However, in the last few years, an…”
Get full text

CD4 and CD8 T-cell positive selection increases the robustness of the CD22 CAR T-cell manufacturing process by Highfill, S.L, Jin, J, Fellowes, V, Ren, J, Ramakrishna, S, Fry, T, Stroncek, D

Get full text

Characterization of BMSC subpopulations by using novel single cell sequencing technology by Jin, P, Liu, S, Bae, H, Zhao, Y, Shi, R, Chen, J, Ren, J, Highfill, S.L, Stroncek, D

Get full text

Use of Elutriated Lymphocytes for Manufacturing CD19-Chimeric Antigen Receptor T Cells Improves the Quantity of Transduced T Cells in the Final Product by Stroncek, D, Ren, J, Sabatino, M, Khuu, H, Lee, D.W, Mackall, C

Get full text

The age of subject affects the proliferation and accounts for the major heterogeneity of clinical Bone Marrow Stromal Cells that are manufactured in a single center by Ren, J, Jin, P, Tran, M, England, L, Wang, H, Civini, S, Robey, P, Sabatino, M, Stroncek, D

Get full text

Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers by Stroncek, John D, Grant, Bryan S, Brown, Melissa A, Povsic, Thomas J, Truskey, George A, Reichert, William M

“…The lack of easily isolated autologous endothelial cell (EC) sources is one of the major challenges with vascular tissue engineering interventions. This…”
Get more information

Instructional PowerPoint presentations for cutaneous wound healing and tissue response to sutures by Stroncek, John D., Bell, Nicole, Reichert, W. Monty

“…Wound healing is an intricate process involving the interaction of cells and molecules, resulting in a complex series of events that change the morphology and…”
Get full text

Selective depletion of alloreactive donor t cells with adenosine—clinical scale up for allogeneic stem cell transplantation by Battiwalla, M, Zhang, N, Li, Z, Whitehill, G, Wong, S, Jain, P, Ito, S, Muranski, P, Highfill, S.L, Stroncek, D, Barrett, J

Get full text

In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin by Stroncek, John D, Xue, Yujing, Haque, Nabila, Lawson, Jeffrey H, Reichert, William M

“…This study investigated the augmentation of endothelial progenitor cell (EPC) thromboresistance by using gene therapy to overexpress thrombomodulin (TM), an…”
Get more information

The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study by Silliman, Christopher C., Paterson, Andrew J., Dickey, William O., Stroncek, David F., Popovsky, Mark A., Caldwell, Sherrie A., Ambruso, Daniel R.

“…BACKGROUND: Transfusion‐related acute lung injury (TRALI) is clinically similar to the adult respiratory distress syndrome (ARDS) and has been linked to the…”
Get full text

Granulocyte gene polymorphisms and mutations: effects on immune response and neutrophil proliferation by Stroncek, D.

Get full text

Patient-derived endothelial progenitor cells improve vascular graft patency in a rodent model by Stroncek, J.D., Ren, L.C., Klitzman, B., Reichert, W.M.

“…Late outgrowth endothelial progenitor cells (EPCs) derived from the peripheral blood of patients with significant coronary artery disease were sodded into the…”
Get full text

Patient‐specific transfusion‐related acute lung injury by Muniz, M., Sheldon, S., Schuller, R. M., Young, N. S., Klein, H. G., Leitman, S. F., Stroncek, D. F.

“…Transfusion‐related acute lung injury (TRALI) is one of the leading causes of transfusion‐associated mortality. The inadvertent transfusion of neutrophil…”
Get full text

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells by Stroncek, D F, Clay, M E, Petzoldt, M L, Smith, J, Jaszcz, W, Oldham, F B, McCullough, J

“…Granulocyte-colony-stimulating factor (G-CSF) has been used in patients to increase the level of circulating hematopoietic progenitors. Although G-CSF has been…”
Get more information

Venous injection of a triphasic calcium-based implant in a sheep model of pulmonary embolism demonstrates minimal acute systemic effects by Constant, Caroline, Stroncek, John D., Zeiter, Stephan, Arens, Daniel, Nehrbass, Dirk, Gehweiler, Dominic, Menzel, Ursula, Benneker, Lorin M., Hill, Ronald S., Albers, Christoph E.

“…Purpose Implant leakage is the most common complication of vertebral augmentation. Alternative injectable materials must demonstrate intravascular safety…”
Get full text

In vitro injection of osteoporotic cadaveric femurs with a triphasic calcium‐based implant confers immediate biomechanical integrity by Stroncek, John D., Shaul, Jonathan L., Favell, Dominique, Hill, Ronald S., Huber, Bryan M., Howe, James G., Bouxsein, Mary L.

“…ABSTRACT Current pharmaceutical therapies can reduce hip fractures by up to 50%, but compliance to treatment is low and therapies take up to 18 months to…”
Get full text